Reduced VGLUT2 expression increases motor neuron viability in Sod1G93A mice

被引:32
作者
Wootz, Hanna [1 ]
Enjin, Anders [1 ]
Wallen-Mackenzie, Asa [1 ]
Lindholm, Dan [2 ]
Kullander, Klas [1 ]
机构
[1] Uppsala Univ, Dept Neurosci, S-75123 Uppsala, Sweden
[2] Biomed Helsinki, Minerva Med Inst, Helsinki, Finland
基金
英国医学研究理事会;
关键词
ALS; Amyotrophic lateral sclerosis; Glutamate; Vglut2; Vesicular glutamate transporters; Excitotoxicity; Motor neuron; Neurodegeneration; Motor neuron subpopulations; Calca; Chondrolectin; Chodl; ERRb; AMYOTROPHIC-LATERAL-SCLEROSIS; VESICULAR GLUTAMATE TRANSPORTERS; TRANSGENIC MOUSE MODEL; PROLONGS SURVIVAL; SPINAL-CORD; DISEASE; LOCALIZATION; ALS; MOTONEURONS; EXCITOTOXICITY;
D O I
10.1016/j.nbd.2009.09.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glutamate-induced excitotoxicity has been suggested to influence pathogenesis in amyotrophic lateral sclerosis (ALS). Vesicular glutamate transporters (VGLUTs) are responsible for transport of glutamate into synaptic vesicles. Nerve terminals that envelop motor neurons in the spinal cord contain VGLUT2 and are likely responsible for most glutamate release on motor neurons. The role of VGLUT2 in ALS and its potential role to influence motor neuron survival have not previously been studied. Here, in a mouse model of ALS. we show that genetic reduction of VGLUT2 protein levels rescues motor neurons in the lumbar spinal cord and in the brainstem as well as neuromuscular junctions in tibialis anterior. Although the number of remaining motor neurons increased. neither disease onset nor life span was affected. We also show that the motor neuron subpopulation-specific markers calcitonin/calcitonin-related polypeptide alpha (Calca) and estrogen related receptor beta (ERR beta) respond in a similar way to reduced VGLUT2 as the whole motor neuron population suggesting that the rescued motor neurons are not of a particular motor unit type. Taken together, this suggests that reduced levels of VGLUT2 decrease motor neuron degeneration but do not prevent loss of motor neuron function in the SOD1(G93A) mouse model for ALS. (C) 2009 Elsevier Inc. All rights reserved
引用
收藏
页码:58 / 66
页数:9
相关论文
共 47 条
  • [1] Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole
    Albo, F
    Pieri, M
    Zona, C
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (02) : 200 - 207
  • [2] Augusto V., 2004, BRAZ J MORPHOL SCI, V21, P89, DOI DOI 10.1055/s-00040444
  • [3] Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels
    Bendotti, C
    Tortarolo, M
    Suchak, SK
    Calvaresi, N
    Carvelli, L
    Bastone, A
    Rizzi, M
    Rattray, M
    Mennini, T
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 79 (04) : 737 - 746
  • [4] ALS:: A disease of motor neurons and their nonneuronal neighbors
    Boillee, Sverine
    Vande Velde, Christine
    Cleveland, Don W.
    [J]. NEURON, 2006, 52 (01) : 39 - 59
  • [5] ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
    Bruijn, LI
    Becher, MW
    Lee, MK
    Anderson, KL
    Jenkins, NA
    Copeland, NG
    Sisodia, SS
    Rothstein, JD
    Borchelt, DR
    Price, DL
    Cleveland, DW
    [J]. NEURON, 1997, 18 (02) : 327 - 338
  • [6] Neuromuscular development in the absence of programmed cell death: Phenotypic alteration of motoneurons and muscle
    Buss, Robert R.
    Gould, Thomas W.
    Ma, Jianjun
    Vinsant, Sharon
    Prevette, David
    Winseck, Adam
    Toops, Kimberly A.
    Hammarback, James A.
    Smith, Thomas L.
    Oppenheim, Ronald W.
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (52) : 13413 - 13427
  • [7] Expression and localization of CHODLΔE/CHODLfΔE, the soluble isoform of chondrolectin
    Claessens, An
    de Vijver, Koen Van
    Van Bockstaele, Dirk R.
    Wauters, Jan
    Berneman, Zwi N.
    Van Marck, Eric
    Merregaert, Joseph
    [J]. CELL BIOLOGY INTERNATIONAL, 2007, 31 (11) : 1323 - 1330
  • [8] INHIBITION BY RILUZOLE OF ELECTROPHYSIOLOGICAL RESPONSES MEDIATED BY RAT KAINATE AND NMDA RECEPTORS EXPRESSED IN XENOPUS-OOCYTES
    DEBONO, MW
    LEGUERN, J
    CANTON, T
    DOBLE, A
    PRADIER, L
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (2-3) : 283 - 289
  • [9] The pharmacology and mechanism of action of riluzole
    Doble, A
    [J]. NEUROLOGY, 1996, 47 (06) : S233 - S241
  • [10] Clinical neurophysiology of ALS
    Eisen, A
    Swash, M
    [J]. CLINICAL NEUROPHYSIOLOGY, 2001, 112 (12) : 2190 - 2201